What smell and taste disorders by SARS-CoV-2 do we know? Predictive value of the Venezuelan Olfactory Test and RT-PCR molecular analysis in COVID-19 infection

R. Pieruzzini, C. Ayala-Grosso, J. de Jesus Navas, W. Rodríguez, N. Parra, E. Luque, A. Sánchez-Gago, S. Gonzalez, A. Hagobian, A. Grullón, K. Díaz, M. Morales, M. De Jesus, S. Peña, L. Rodríguez, L. Peña, A. Asaro, M. Magris
{"title":"What smell and taste disorders by SARS-CoV-2 do we know? Predictive value of the Venezuelan Olfactory Test and RT-PCR molecular analysis in COVID-19 infection","authors":"R. Pieruzzini, C. Ayala-Grosso, J. de Jesus Navas, W. Rodríguez, N. Parra, E. Luque, A. Sánchez-Gago, S. Gonzalez, A. Hagobian, A. Grullón, K. Díaz, M. Morales, M. De Jesus, S. Peña, L. Rodríguez, L. Peña, A. Asaro, M. Magris","doi":"10.4193/rhinol/21.003","DOIUrl":null,"url":null,"abstract":"Background: Smell and taste disorders are reported very frequently and at an early stage in SARS-CoV-2 infectious disease. These symptoms could be sensitive and specific to establish possible severity of the infection, and may suggest the flow of decisions as to further therapy. Objective: We asked whether smell and taste impairment are earlier and more sensitive symptoms than the RT-PCR molecular assays for SARS-CoV-2 detection. Methods: Subjects (N=275) with a probable COVID-19 diagnosis were classified as follows: Symptomatic with chemosensory dysfunction, symptomatic without chemosensory dysfunction, and asymptomatic. Validated unbiased testing of the chemosensory dysfunction was performed by means of the Venezuelan Olfactory Test and taste test. Nasal swabs and blood samples were analyzed by RT-PCR molecular analysis a rapid diagnostic test to detect the SARS-CoV-2 virus and viral antibodies, respectively. Smell and taste testing and RT-PCR were performed every 3 to 5 days to patients until full recovery. Results: Out of 144 patients that were positive for SARS-CoV-2: 45.83% had COVID-19 symptoms, smell and taste disorders; 23.61% had COVID-19 symptoms but not smell or taste disorders, and 30.55% were asymptomatic. Mild hyposmia and hypogeusia were frequently associated with SARS-CoV-2 symptoms. Recovery from chemosensory dysfunction occurred between day 3 and 14. RT-PCR becomes negative after 21 days. The Venezuelan Olfactory Test and taste test has a 61.68% positive predictive value, 45.83% sensitivity, and 68.7% specificity for SARS-CoV-2. Conclusions: Smell and taste disorders are associated symptoms with SARS-CoV-2 infection, but not a predictor of the disease, as compared to the molecular RT-PCR test.","PeriodicalId":74737,"journal":{"name":"Rhinology online","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rhinology online","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4193/rhinol/21.003","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Smell and taste disorders are reported very frequently and at an early stage in SARS-CoV-2 infectious disease. These symptoms could be sensitive and specific to establish possible severity of the infection, and may suggest the flow of decisions as to further therapy. Objective: We asked whether smell and taste impairment are earlier and more sensitive symptoms than the RT-PCR molecular assays for SARS-CoV-2 detection. Methods: Subjects (N=275) with a probable COVID-19 diagnosis were classified as follows: Symptomatic with chemosensory dysfunction, symptomatic without chemosensory dysfunction, and asymptomatic. Validated unbiased testing of the chemosensory dysfunction was performed by means of the Venezuelan Olfactory Test and taste test. Nasal swabs and blood samples were analyzed by RT-PCR molecular analysis a rapid diagnostic test to detect the SARS-CoV-2 virus and viral antibodies, respectively. Smell and taste testing and RT-PCR were performed every 3 to 5 days to patients until full recovery. Results: Out of 144 patients that were positive for SARS-CoV-2: 45.83% had COVID-19 symptoms, smell and taste disorders; 23.61% had COVID-19 symptoms but not smell or taste disorders, and 30.55% were asymptomatic. Mild hyposmia and hypogeusia were frequently associated with SARS-CoV-2 symptoms. Recovery from chemosensory dysfunction occurred between day 3 and 14. RT-PCR becomes negative after 21 days. The Venezuelan Olfactory Test and taste test has a 61.68% positive predictive value, 45.83% sensitivity, and 68.7% specificity for SARS-CoV-2. Conclusions: Smell and taste disorders are associated symptoms with SARS-CoV-2 infection, but not a predictor of the disease, as compared to the molecular RT-PCR test.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
我们知道SARS-CoV-2有哪些嗅觉和味觉障碍?委内瑞拉嗅觉测试和RT-PCR分子分析对COVID-19感染的预测价值
背景:在SARS-CoV-2传染病中,嗅觉和味觉障碍的报告非常频繁,并且在早期阶段。这些症状可能是敏感和特异性的,可以确定感染的可能严重程度,并可能提示进一步治疗的决定流程。目的:探讨嗅觉和味觉障碍是否比RT-PCR分子检测更早、更敏感。方法:将可能诊断为COVID-19的受试者(N=275)分为有症状的化学感觉功能障碍、有症状的无化学感觉功能障碍和无症状。通过委内瑞拉嗅觉测试和味觉测试对化学感觉功能障碍进行了有效的无偏测试。采用RT-PCR分子分析方法对鼻拭子和血液样本进行分析,RT-PCR分子分析方法是一种检测SARS-CoV-2病毒和病毒抗体的快速诊断方法。每3 ~ 5 d进行嗅觉味觉检测和RT-PCR检测,直至患者完全康复。结果:144例SARS-CoV-2阳性患者中:45.83%出现新冠肺炎症状、嗅觉和味觉障碍;23.61%有新冠肺炎症状,但没有嗅觉和味觉障碍,30.55%无症状。轻度缺氧和缺氧常与SARS-CoV-2症状相关。化学感觉功能障碍在第3天至第14天恢复。21天后,RT-PCR变为阴性。委内瑞拉嗅觉测试和味觉测试对SARS-CoV-2的阳性预测值为61.68%,敏感性为45.83%,特异性为68.7%。结论:与分子RT-PCR检测相比,嗅觉和味觉障碍与SARS-CoV-2感染相关,但不是疾病的预测因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
8 weeks
期刊最新文献
COVID-19 control protocol for rhinologic surgery Trends in dupilumab persistence among patients with chronic rhinosinusitis with nasal polyps Dupilumab as an emerging treatment for refractory allergic fungal rhinosinusitis: a case series and literature review Capturing qualitative olfactory dysfunction with PARPHAIT: the parosmia, phantosmia, and anosmia test Prevalence of smell and taste dysfunction in different clinical severity groups of COVID-19 patients
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1